Stay updated on Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.

Latest updates to the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedThe only observed change is a revision update from v3.3.1 to v3.3.2 on the page header/footer; no study content, eligibility criteria, dates, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page now displays Revision: v3.3.1 in place of the previous Revision: v3.2.0.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page no longer displays a general funding-status notice. This change has no impact on the study information or results presented on the page.SummaryDifference0.4%

- Check35 days agoChange DetectedAdded related topics 'Ovarian cancer' and 'MedlinePlus Genetics' to the Related Topics section of the study page.SummaryDifference0.6%

- Check42 days agoChange DetectedThe page no longer includes related topics 'Ovarian cancer' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

Stay in the know with updates to Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.